BCL2 and B-cell chronic lymphocytic leukemia: Conversely, BCL2 expression was not modulated by the compound in T cells isolated from patients with CLL, thereby reinforcing the notion that EC-7072 is highly efficient at inducing leukemia cell apoptosis compared to other immune cell subsets in patients with CLL (Supplementary Figures 7C,D).